Paradigm shift in the treatment of tuberous sclerosis: Effectiveness of everolimus

Abstract excerpt

Tuberous sclerosis complex (TSC) is an autosomal dominant disease characterised by abnormal cell proliferation and differentiation that affects multiple organs and can lead to the growth of hamartomas. Tuberous sclerosis complex is caused by the disinhibition of the protein mTOR (mammalian target of rapamycin). In the past, various therapeutic approaches, even if only symptomatic, have been attempted to improve...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Tuberous Sclerosis Complex Research